Geraldine Pannu - Dec 31, 2022 Form 4 Insider Report for Processa Pharmaceuticals, Inc. (PCSA)

Role
Director
Signature
/s/ Geraldine Pannu by Michael B. Kirwan, as Attorney-in-Fact
Stock symbol
PCSA
Transactions as of
Dec 31, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 04:33 PM
Previous filing
Aug 9, 2022
Next filing
Jan 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCSA Common Stock Options Exercise +18.2K +161.58% 29.5K Dec 31, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCSA Restricted Stock Award $0 +30K $0.00 30K Jan 1, 2023 Common Stock 30K $0.00 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Vesting of time-based restricted shares.
F2 The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.